Incyte

IMMUNOLOGY THERAPEUTIC SPECIALIST (HS) - JACKSON, MS

Incyte$140K — $230K *
Pharmaceuticals & Biotech
Less than 5 years of experience
Job Overview by Ladders

Qualifications

  • Bachelor's degree or equivalent professional experience.
  • Proven success in pharmaceutical, biotech, or specialty healthcare sales.
  • Experience in competitive specialty markets and/or systemic biologics or oral JAK therapies.
  • Cross-functional experience partnering with Market Access, Medical Affairs, Marketing.
  • Strong clinical selling skills and ability to communicate complex scientific information.
  • Ability to travel within territory; must reside in assigned geography with a valid driver's license.
  • 3+ years of pharmaceutical, biotech, or specialty healthcare sales experience (preferred).
  • Dermatology and/or immunology sales experience, particularly with underserved patient populations (preferred).

Responsibilities

  • Execute territory and account plans to achieve sales goals and support a successful product launch.
  • Build trusted relationships with dermatologists, key opinion leaders, academic centers, and large dermatology practices.
  • Deliver compelling, evidence-based clinical discussions on disease state, treatment guidelines, efficacy, safety, and patient management.
  • Navigate complex access and reimbursement environments, collaborating with Market Access and Patient Services teams.
  • Provide field insights and partner cross-functionally with Medical Affairs, Marketing, and Access teams.

Benefits

  • Opportunity for career growth within a leading company in the pharmaceutical field.
  • Collaborative work environment with cross-functional teams.
  • Engagement with industry experts and key opinion leaders in dermatology and immunology.
  • Chance to contribute significantly to the launch of innovative treatments for patients.
Full Job Description
What You'll Do
  • Execute territory and account plans to achieve sales goals and support a successful product launch.
  • Build trusted relationships with dermatologists, key opinion leaders, academic centers, and large dermatology practices.
  • Deliver compelling, evidence-based clinical discussions on disease state, treatment guidelines, efficacy, safety, and patient management.
  • Navigate complex access and reimbursement environments, collaborating with Market Access and Patient Services teams to help patients start and stay on therapy.
  • Provide field insights and partner cross-functionally with Medical Affairs, Marketing, and Access teams to drive business success.

What We're Looking For
  • Bachelor's degree or equivalent professional experience.
  • Proven success in pharmaceutical, biotech, or specialty healthcare sales.
  • Experience in competitive specialty markets and/or systemic biologics or oral JAK therapies with a track record of strong sales results.
  • Cross-functional experience partnering with Market Access, Medical Affairs, Marketing.
  • Strong clinical selling skills with the ability to communicate complex scientific information.
  • Ability to travel within territory; must reside in assigned geography. Valid driver's license required.

Preferred Qualifications
  • 3+ years of pharmaceutical, biotech, or specialty healthcare sales experience.
  • Dermatology and/or immunology sales experience; Hidradenitis Suppurativa (HS) or other rare/under-served patient population commercial experience.
  • Product launch experience and a demonstrated record of exceeding sales goals.
  • Knowledge of patient access, reimbursement, and fulfillment processes.
  • Familiarity with institutional systems, academic centers, and large dermatology groups, with direct selling in these settings.

Pay Range

USD $140,000.00 - USD $230,000.00 /Yr.

About Incyte

Incyte is a biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics. The company was founded in 1991 and is headquartered in Wilmington, Delaware. Incyte's main focus is on oncology, inflammation, and autoimmunity. The company's flagship product, Jakafi, is a JAK1/JAK2 inhibitor used to treat myelofibrosis and polycythemia vera. Incyte has a number of other products in development, including itacitinib, a JAK1 inhibitor for the treatment of graft-versus-host disease, and pemigatinib, a FGFR inhibitor for the treatment of cholangiocarcinoma.
Learn more about Incyte
Size
2,094 employees
Market Cap
$17.6 billion
Industry
Net Income
-$295.7 million
Founded
1991
5 Year Trend
+22%
Revenue
$2.6 billion
NASDAQ

Similar Jobs

More Jobs at Incyte

More Pharmaceuticals & Biotech Jobs

Find similar IMMUNOLOGY THERAPEUTIC SPECIALIST (HS) - JACKSON, MS jobs: